Yatharth Hospital & Trauma Care Services Limited

Q3FY25 CONCALL

  1. Management is very confident in positive outcome from the income-tax case and the cash, assets attached will be released soon within few weeks. The whole case is expected to close in this CY with negligible monetary impact.

  2. Q3 is generally a weak quarter still 30% YoY and 1% QoQ indicates strong operating performance.

  3. Two recent aquisitions ( 700 beds ) are set to operationalize in Q1FY26, ARPOB potential can be 35k+ and approximately 630 beds are census beds.

  4. Greater Faridabad hospital will breakeven in 1 or 2 quarters.

  5. Deloitte is the internal auditor from last quarter, this gives a good comfort on corporate governance aspect.

  6. Receivable days to go down to 75 days in coming years.

  7. Government business mix will be 35% for FY25.

  8. Investment in cutting edge technologies to deliver highest quality healthcare services in the super speciality departments ( oncology, transplants etc… ) to drive ARPOB growth eventually bridging the gap between peers

5 Likes

Yatharth Hospitals -

Q3 FY 25 results and concall highlights -

Revenues - 219 vs 167 cr, up 31 pc, led by operationalisation of Greater Faridabad hospital

EBITDA - 55 vs 47 cr ( margins @ 25 vs 28 pc ). Employee expenses were up at 42 vs 30 cr YoY. Other expenses were up @ 79 vs 58 cr YoY

Depreciation @ 17 vs 8 cr YoY

PAT - 30 vs 29 cr

Most of the additional costs relate to operationalisation of a new hospital ( greater Faridabad ) and the losses incurred thereof

Occupancy @ 60 vs 52 pc
ARPOB @ Rs 30.6k vs Rs 29.3k

Hospital wise revenue contribution, percentage contribution to total revenues -

Greater Noida - 66 vs 58 cr, 30 vs 35 pc YoY
Noida Extension - 79 vs 55 cr, 36 vs 33 pc YoY
Noida - 44 vs 43 cr, 20 vs 26 pc YoY
Jhansi - 18 vs 9 cr, 9 vs 6 pc YoY
Faridabad - 11 vs NIL cr, 5 vs NIL pc YoY

Top contributors ( therapy wise ) -

Oncology - 21 pc
Cardio - 12 pc
Nephro and Urology - 10 pc
Internal Medicine - 10 pc
Neuro - 9 pc
GI - 7 pc
Ortho - 6 pc
General Surgery - 6 pc
Gynae - 6 pc
Pulmonology - 6 pc
Paediatrics and Others - 7 pc

Company raised 625 cr in Q3 via QIP. Utilisation of QIP funds is as follows -

Debt repayment - 96 cr
Funding of recent acquisitions - 151 cr
Purchase of Medical Equipment - 217 cr
General corporate expenses - 140 cr
Total - 604 cr

Anchor investors in the QIP included - Kotak MF, SBI Life, Bandhan MF, Carnelian PMS, Taurus MF, Canara HSBC Life, Universal Sompo General

Update on acquisitions -

  1. Acquired 60 pc stake in a 400 bedded hospital in Faridabad. Built in 2 acres, Muti speciality, located in Sec 20. Operations to commence in Q1 FY 26
  2. Acquired 300 bedded hospital in Model Town ( 100 pc stake ), New Delhi. Located in a high per capita income colony, has a large catchment of residential and institutional clients. Operations to commence in Q1 FY 26

Once the new Faridabad and Model Town hospital goes live ( in Q1 Next FY ), Yatharth will become the 3rd largest hospital chain in NCR after Appolo and Fortis. At no 4,5 shall be Medanta, Paras Health

Occupancy levels @ current hospitals -

Greater Noida - 400 beds, occupancy @ 65 pc
Noida - 250 beds, occupancy @ 80 pc
Noida Extension - 450 beds, occupancy @ 60 pc
Jhansi - 305 beds, occupancy @ 50 pc
Greater Faridabad - 200 beds, occupancy @ 31 pc

Model Town, 2nd Faridabad hospital to go live in Q1 FY 26. Post their operationalisation, the total bed capacity will reach 2300 beds. Company aims to take this upto 3000 beds by end of FY 28 - via organic + inorganic routes

Company has appointed Deloitte as their Internal auditor - to manage risks, strengthening financial management

IT raids conducted on the company in 2023 and the IT department had frozen certain amount of money pending resolution of the case. However, company is allowed to use that money after obtaining permissions from the IT department. The company has been doing so and is being allowed to do so in recent past. Company does not fore see any significant losses / impairment from these events and is confident of a favourable resolution

Company expects this provisional attachment of Rs 60 cr with the IT department to get released in near future

A new hospital generally takes about 18 - 24 months to break even. Expect the same from the two new Faridabad and one new Model Town hospital

Greater Faridabad hospital is picking up momentum and is doing well in Q4 as well

It generally takes 2 yrs kind of time to complete an IT case in India. This case has been on for > 14 months now. Company expects a full resolution in next FY

Remaining cash on books will be used for brownfield expansions @ Greater Noida, Noida hospitals

As the new hospitals on online in Q1 next FY, expect further increase in Employees cost + Depreciation etc. However, at the same time - benefits from the Greater Faridabad hospital should start to flow in by that time

Qtly Depreciation rate for next FY should be around 20 cr wef next FY

In next 2 yrs, company expects to bring down the Govt business to less than 25 pc of the total business vs 35 pc currently. This should also help the company to accelerate their ARPOB growth

The new hospitals that the company is starting have a very low share of Govt business ( < 15 pc ) - should be ARPOB, margin accretive

Company expects to keep growing topline @ 25-30 pc rate for FY 26 as well

The new Faridabad and New Delhi hospital are expected to have ARPOBs > 35k

Business in Jan 25 was buoyant. Q4 is generally the strongest Qtr for hospitals in North India

Disc: holding, biased, not a buy/sell recommendation, not SEBI registered. IMO - once the IT hangover is over, the stock may be in for a re-rating

5 Likes

After sharp correction, stock looks worth studying, risk / rewards ratio looks favorable. Nuvama expect company to make EPS of 13 / 19 / 28 for FY25 / FY26 / FY27 respectively, as per which company is currently trading at 15x FY27 earning, which looks cheap compared to industry / other players.

@chikspat - have you ever met with the management or taken any service from the hospital? Would be great if could share your experience

Request people from Delhi / NCR to share their experience of the hospital (thanks @Rushil_Kumar for sharing your experience)

lohiyaakshay08
Never met management nor avail there services.

1 Like

Management is proactively trying to get rid of the negative narrative about CG. 2 different agencies to audit the use of the funds from IPO and QIP. I’m quite confident about due diligence now atleast. @Naval still you see any red flags ?

67a9668a-cf65-41ed-bb7e-2736892df096.pdf (953.9 KB)
d852bf47-fe54-40fd-ace7-09130aee347f.pdf (1.1 MB)

3 Likes

Desperate times, desperate measures - the promoters bought shares and put out a press release to stop the bleeding! :smiling_face_with_tear:

6 Likes

They should focus on running hospital rather than what’s happening with the stock price!!

1 Like

I request the community to provide value , bring reasonable sources and data to discuss issues before pointing any, whether positive or negative, it elevates quality of discussion and helps everyone learn. I am not passing comment/judgement on any one particular posting, but it should not become like some social message boards. This community stands for high quality analysis with reasonable scrutiny.

5 Likes

Promoter should focus on both, because they are biggest stakeholder in yatharth Hospital.

Nope…The stock price is dependent on the inherent value of the business & not the other way around so the price would correct itself if they just keep focusing on the business while they caring about the stock price could let them take extreme measures or even unethical measures as we have seen in many stocks before!!

4 Likes

image

This buying aligns with his previous purchases back in Nov 2023, the recent buying is below these levels

2 Likes

Could you please share link of this report?

There was buying in MF counter during the panic sell last month. Bandhan MF & ICICI prudential pharma funds were the top buyers.

5 Likes

even before the rally ICICI bought shares around 410 price. They might have added near about same levels.


Yatharth having the highest revenue growth TTM in complete hospital sector and also not bad PAT growth. I don’t know why this much PE derating is happening to the stock. I’m assuming that due to Margin contraction ?
image
The management is guiding for 30% YOY growth for the next financial year and also margin expansion as their new hospital becomes operational.
Hoping for their price revival and PE rerating in upcoming quarters. And also I think hospital sector being the strongest in this market correction so this might help as well.

6 Likes